Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glibenclamide in hypotonia-cystinuria syndrome (PREPL deficiency)
2012-000814-13Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of glibenclamide in Hypotonia-Cystinuria Syndrome (HCS) and PREPL deficiency, sponsored by UZ Leuven. Primary endpoints: Evolution of hypotonia with glibenclamide, Reversibility of effect after glibenclamide discontinuation and 1 more. Started Feb 2012; status: completed.
02
Drugs
glibenclamide
03
Conditions
Hypotonia-Cystinuria Syndrome (HCS)PREPL deficiency
Beyond the preview
Go deeper on 2012-000814-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000814-13.